Mouse adenovirus (MAV-1) expression in primary human endothelial cells and generation of a full-length infectious plasmid

Gene Therapy

Volumn 6, Issue 7, 1999, Pages 1291-1297

  Nguyen, T T ^a   Nery, J P ^a,c   Joseph, S ^a,d   Rocha, C E ^a   Carney, G E ^b,e   Spindler, K R ^b   Villarreal, L P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of Georgia ^*  (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e OREGON STATE UNIVERSITY   (United States)

Author keywords

Endothelial; Full length clone; Human; Mouse adenovirus

Indexed keywords

VIRUS DNA;

ADENOVIRUS; ARTICLE; CONTROLLED STUDY; DNA TRANSFECTION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; NONHUMAN; PLASMID; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS INFECTIVITY;

ADENOVIRIDAE; ANIMALS; CLONING, MOLECULAR; DNA; ENDOTHELIUM; GENE THERAPY; GENETIC VECTORS; HUMANS; MICE; PLASMIDS; RECOMBINATION, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

ADENOVIRIDAE; DNA VIRUSES; HUMAN ADENOVIRUS; MURINE ADENOVIRUS 1;

EID: 0032773548     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300949     Document Type: Article

References (35)

1. Graham FL, Prevec L. Methods for construction of adenovirus vectors. Mol Biotechnol 1995; 3: 207-220.
2. Kochanek S et al. A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and β-galactosidase. Proc Natl Acad Sci USA 1996; 93: 5731-5736.
3. Haecker SE et al. In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes. Hum Gene Ther 1996; 7: 1907-1914.
4. McGrory WJ, Bautista DS, Graham FL. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology 1988; 163: 614-617.
5. Chartier C et al. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol 1996; 70: 4805-4810.
6. Hartley JW, Rowe WP. A new mouse virus apparently related to the adenovirus group. Virology 1960; 11: 645-647.
7. Gall J, Kass-Eisler A, Leinwand L, Falck-Pedersen E. Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes. J Virol 1996; 70: 2116-2123.
8. Wickham TJ, Carrion ME, Kovesdi I. Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs. Neuromusc Dis 1997; 7: 284-298.
9. Douglas JT, Curiel DT. Strategies to accomplish targeted gene delivery to muscle cells employing tropism-modified adenoviral vectors. Neuromusc Dis 1997; 7: 284-298.
10. Krasnykh VN, Mikheeva GV, Douglas JT, Curiel DT. Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J Virol 1996; 70: 6839-6846.
11. Blailock ZR, Rabin ER, Melnick JL. Adenovirus endocarditis in mice. Science 1967; 157: 69-70.
12. Heck FCJ, Sheldon WG, Gleiser CA. Pathogenesis of experimentally produced mouse adenovirus infection in mice. Am J Vet Res 1972; 33: 841-846.
13. Guida JD et al. Mouse adenovirus type 1 causes a fatal hemorrhagic encephalomyelitis in adult C57BL/6 but not BALB/c mice. J Virol 1995; 69: 7674-7681.
14. Kring SC, King CS, Spindler KR. Susceptibility and signs associated with mouse adenovirus type 1 infection of adult outbred Swiss mice. J Virol 1995; 69: 8084-8088.
15. Engel JP. Viral upper respiratory infections. Semin Resp Infect 1995; 10: 3-13.
16. Ketner G et al. Efficient manipulation of the human adenovirus genome as an infectious yeast artificial chromosome clone. Proc Natl Acad Sci USA 1994; 91: 6186-6190.
17. Hirt B. Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol 1967; 26: 365-369.
18. Graham FL, Prevec L. Manipulation of adenovirus vectors. In: Murray EJ (ed). Gene Transfer and Expression Protocols. Humana Press: Clifton, NJ, 1991, pp 109-128.
19. Graham FL, van der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973; 52: 456-467.
20. Larsen SH. Evolutionary variants of mouse adenovirus containing cellular DNA sequences. Virology 1982; 116: 573-580.
21. Stoflet ES, Koeberl DD, Sarkar G, Sommer SS. Genomic amplification with transcript sequencing. Science 1988; 239: 491-494.
22. Thornton SC, Mueller SN, Levine EM. Human endothelial cells: use of heparin in cloning and long-term serial cultivation. Science 1983; 222: 623-625.
23. Gimbrone MAJ. Culture of vascular endothelium. Prog Hemost Thromb 1976; 3: 1-28.
24. Shinagawa M et al. A rapid and simple method for preparation of adenovirus DNA from infected cells. Microbiol Immunol 1983; 27: 817-822.
25. Cox GA et al. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity (see comments). Nature 1993; 364: 725-729.
26. Wang RF, Kushner SR. Construction of versatile low copy number vectors for cloning, sequencing and gene expression in Escherichia coli. Gene 1991; 100: 195-199.
27. Wiegand RC, Beattie KL, Holloman WK, Radding CM. Uptake of homologous single-stranded fragments by superhelical DNA. III. The product and its enzymic conversion to a recombinant molecule. J Mol Biol 1977; 116: 805-824.
28. Schaack J, Ho WY, Freimuth P, Shenk T. Adenovirus terminal protein mediates both nuclear matrix association and efficient transcription of adenovirus DNA. Genes Dev 1990; 4: 1197-1208.
29. Miyake S et al. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci USA 1996; 93: 1320-1324.
30. Kring SC, Spindler KR. Lack of effect of mouse adenovirus type 1 infection on cell surface expression of major histocompatibility complex class I antigens. J Virol 1996; 70: 5495-5502.
31. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294-5299.
32. Meissner JD et al. Completion of the DNA sequence of mouse adenovirus type 1: sequence of E2B, L1, and L2 (18-51 map units). Virus Res 1997; 51: 53-64.
33. Ball AO, Williams ME, Spindler KR. Identification of mouse adenovirus type 1 early region 1: DNA sequence and a conserved transactivating function. J Virol 1988; 62: 3947-3957.
34. Kusano K, Nakayama K, Nakayama H. Plasmid-mediated lethality and plasmid multimer formation in an Escherichia coli recBC sbcBC mutant. Involvement of RecF recombination pathway genes. J Mol Biol 1989; 209: 623-634.
35. Hanahan D. Studies on transformation of Escherichia coli with plasmids. J Mol Biol 1983; 166: 557-580.